期刊文献+

基质金属蛋白酶9基因-1562C/T多态性与新疆维吾尔族心肌梗死的相关性研究 被引量:4

Association of MMP9 gene -1562 C/T polymorphism with myocardial infarction in Uighur population of Xinjiang
原文传递
导出
摘要 目的 探讨新疆维吾尔族人群基质金属蛋白酶9(matrix metalloproteinase 9,MMP9)基因启动子区-1562C/T多态性与心肌梗死(myocardialinfarction,MI)发病的相关性.方法 选择经皮冠状动脉造影检查确诊的维吾尔族心肌梗死患者347例(MI组),以同期冠脉造影阴性、排除冠心病诊断的403例维吾尔族患者为对照组.采用聚合酶链反应-限制性片段长度多态性方法对所有纳入对象MMP9基因-1562C/T多态性进行分析,比较两组间MMP9基因多态性频率分布的差异,并结合造影情况,探讨MMP9基因多态性与MI发病及冠脉狭窄程度的关系.结果 MI组CT+TT基因型频率(27.67%)明显高于对照组(14.14%),两组差异具有统计学意义(χ2=20.99,P<0.01),T等位基因频率在MI组和对照组分别为15.71%、7.56%(χ2=24.57,P<0.01).Logistic回归分析显示,携带-1562T等位基因的个体发生MI的风险大约升高2倍(OR=2.009,95%CI:1.250~3.230);携带T等位基因合并糖尿病的个体发生MI的风险明显升高(OR=3.714,95%CI:1.299~10.773).MMP9基因-1562C/T多态性分布与MI冠脉狭窄程度差异无统计学意义.结论 MMP9基因-1562C/T多态性可能与新疆维吾尔族人群MI茇病具有相关性;-1562T等位基因可能是MI遗传易感性的基因标记之一;-1562T等位基因与糖尿病在MI发生中具有协同作用.MMP9基因-1562C/T多态性与MI冠脉狭窄程度无关. Objective To investigate the association between matrix metalloproteinase 9 gene (MMP9)- 1562C/T polymorphism and myocardial infarction (MI) in Uighur population of Xinjiang.Methods A total of 347 patients with MI evidenced by coronary arteriography, and 403 controls free from coronary artery disease with normal angiograms were recruited for the study. Polymerase chain reactionrestriction fragment length polymorphism (PCR-RFLP) was used to detect the -1562C/T functional promoter polymorphism of the MMP9 gene. The relationship between the polymorphism and the severity of coronary arterial stenosis was analyzed. Results The results showed that the frequency of CT and TT genotypes in patients with MI (27. 67%) was significantly higher than that in controls (14. 14%). The frequencies of the - 1562T allele were 15. 71% and 7. 56% in the MI group and the control group respectively (2 = 24.57, P〈0.01). Logistic regression analysis indicated that the T allele carriers (CT+TT) had significantly increased risk of MI compared with the CC carriers (OR=2. 009, 95%CI: 1. 250-3. 230). Individuals carrying the -1562T allele with diabetes mellitus were at an increased risk of MI (OR=3. 714, 95% CI: 1. 299-10. 773). The frequencies of CT and TT genotypes were not significantly different among MI patients with one, two and three or more significantly diseased vessels (χ2 =0. 491, P=0. 782). Conclusion The - 1562C/T polymorphism in the MMP9 gene promoter is associated with the susceptibility to MI in the Uighur population of Xinjiang. The T allele might be a risk factor of MI. And there was a coordinated effect between the -1562T allele and diabetes mellitus in the development of MI.The -1562C/T polymorphism may not be a predictor of the severity of coronary atherosclerosis.
出处 《中华医学遗传学杂志》 CAS CSCD 北大核心 2011年第2期180-184,共5页 Chinese Journal of Medical Genetics
基金 新疆自治区重大专项课题(200733146-3)
关键词 基质金属蛋白酶9 心肌梗死 维吾尔族 遗传多态性 matrix metalloproteinase 9 myocardial infarction Uighur population genetic polymorphism
  • 相关文献

参考文献19

  • 1Newby AC.Dual role of matrix metalloproteinases (matrixins)in intimal thickening and atherosclerotic plaque rupture.Physiol Rev,2005,85:1-31.
  • 2Cipollone F,Prontera C,Pini B,et al.Overexpression of functionally coupled cyclooxygenase-2 and prostaglandin E synthase in symptomatic atherosclerotic plaques as a basis of prostaglandin E (2)-dependent plaque instability.Circulation,2001,104:921-927.
  • 3Cipollone F,Fazia M,lezzi A,et al.Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans.Circulation,2003,107:1479-1485.
  • 4Loftus IM,Naylor AR,Goodall S,et al.Increased matrix metalloproteinase-9 activity in unstable carotid plaque.A potential role in acute plaque disruption.Stroke,2000,31:40-47.
  • 5Funayama H,Ishikawa SE,Kubo N,et al.Increases in interleukin-6 and matrix metalloproteinases-9 in the infarctrelated coronary artery of acute myocardial infarction.Cire J,2004,68:451-454.
  • 6Morgan AR,Zhang B,Tapper W,et al.Haplotypic analysis of the MMP9 gene in relation to coronary artery disease.J Mol Med,2003,81:321-326.
  • 7Zhang B,Ye S,Herrmann SM,et al.Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis.Circulation,1999,99:1788-1794.
  • 8Haberbosch W,Gardemann A.Gelatinase B C (-1562) T polymorphism in relation to ischaemic heart disease.Scand J Clin Lab Invest,2005,65:513-522.
  • 9Wang J,Warzecha D,Wilcken D,et al.Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis.Clin Sci (Lond).2001,101:87-92.
  • 10唐礼江,陈晓锋,朱敏,沈卫峰,江建军.基质金属蛋白酶-9基因多态性与急性冠状动脉综合征的关联研究[J].中华医学遗传学杂志,2005,22(3):313-316. 被引量:13

二级参考文献15

  • 1Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med, 1992,326 : 242-250.
  • 2Zaltsman AB, Newby AC. Increased secretion of gelatinases A and B from the aortas of cholesterol fed rabbits: relationship to lesion severity.Atherosclerosis, 1997, 130 : 61-70.
  • 3Galis ZS, Sukhova GK, Lark MW, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest, 1994, 94:2493-2503.
  • 4Zhang B, Shu Ye, Stefan-Martin H, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis, Circulation, 1999, 99: 1788-1794.
  • 5Morgan AR, Zhang B, Tapper W, et al. H aplotypic analysis of theMMP-9 gene in relation to coronary artery disease. Haplotypic J Mol Med, 2003,81:321-326.
  • 6Wang J, Warzzecha D, Wilcken D, et al. Polymorphism in the gelatinase B gene and the severity of coronary arterial stenosis. Clin Sci(Lond), 2001,101:87-92.
  • 7Cho HJ,Chae IH, Park KW, et al. Functional polymorphism in the promoter region of the gelatinase B gene in relation to coronary artery disease and restenosis'after percutaneous coronary intervention, J Hun Genet,2002, 47:88-91.
  • 8Burzotta F, Leone AM, Paeiaroni K, et al. G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome. Haematologica, 2004, 89:1134-1138.
  • 9Kullo U, Elwards ED, Schwartz RS. Vulnerable plaque: pathobiology, and clinical implications. Ann Intern Med, 1998, 129: 1050-1060.
  • 10Davics MJ, Richanlson PD, Woolf N, et al. Risk of thrombosis in human athcrosclerotic plaques: role of extracellular lipid, macmphage, and smooth muscle cell content. Br Heart J, 1993, 69:377-381.

共引文献12

同被引文献28

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部